CA 19-9 and CA 125 determination by immunoluminometric assay

J Clin Chem Clin Biochem. 1990 Dec;28(12):919-21. doi: 10.1515/cclm.1990.28.12.919.

Abstract

We evaluated a new immunoluminometric technique (ILMA) for the measurement of the cancer antigens, CA 19-9 and CA 125 in serum. A satisfactory reproducibility was found, coefficients of variation ranging from 4.2 to 7.3% in within-run and between-run assays. The linearity of tests was maintained over a wide concentration range. Mean analytical recovery was 94% for CA 19-9 and 98% for CA 125. A significant agreement between results obtained by immunoradiometric assays and evaluated methods was found both for CA 125 (ILMA = 0.917 IRMA + 1.048; r = 0.966; n = 98) and CA 19-9 (ILMA = 1.156 IRMA + 0.996; r = 0.995; n = 100).

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Antigens, Tumor-Associated, Carbohydrate / blood*
  • Biomarkers, Tumor / blood
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Immunoassay / methods*
  • Immunoassay / statistics & numerical data
  • Immunoradiometric Assay
  • Luminescent Measurements
  • Male
  • Middle Aged
  • Ovarian Neoplasms / blood
  • Ovarian Neoplasms / diagnosis
  • Ovarian Neoplasms / immunology
  • Pancreatic Neoplasms / blood
  • Pancreatic Neoplasms / diagnosis
  • Pancreatic Neoplasms / immunology
  • Reproducibility of Results

Substances

  • Antigens, Tumor-Associated, Carbohydrate
  • Biomarkers, Tumor